E Fund Management Co. Ltd. Sells 2,833 Shares of Danaher Corporation (NYSE:DHR)

Key Points

• E Fund Management Co. Ltd. has reduced its stake in Danaher Corporation by 46.2%, now holding 3,304 shares valued at $677,000 as of the last reporting period.
• Wall Street analysts have mixed views on Danaher, with 18 buy ratings and some instituting price target reductions, the consensus target now at $247.61.
• Danaher reported earnings of $1.80 per share for the latest quarter, exceeding forecasts, with revenues of $5.94 billion marking a 3.4% increase year-over-year.

E Fund Management Co. Ltd. decreased its position in Danaher Corporation (NYSE:DHR - Free Report) by 46.2% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,304 shares of the conglomerate's stock after selling 2,833 shares during the period. E Fund Management Co. Ltd.'s holdings in Danaher were worth $677,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Tokio Marine Asset Management Co. Ltd. grew its stake in Danaher by 2.6% in the 1st quarter. Tokio Marine Asset Management Co. Ltd. now owns 19,480 shares of the conglomerate's stock valued at $3,993,000 after buying an additional 493 shares in the last quarter. NFP Retirement Inc. boosted its holdings in Danaher by 14.7% in the 1st quarter. NFP Retirement Inc. now owns 1,076 shares of the conglomerate's stock valued at $221,000 after purchasing an additional 138 shares during the period. Triglav Skladi D.O.O. bought a new position in Danaher in the 1st quarter valued at $1,025,000. Caitong International Asset Management Co. Ltd boosted its holdings in Danaher by 86.4% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 770 shares of the conglomerate's stock valued at $158,000 after purchasing an additional 357 shares during the period. Finally, S Bank Fund Management Ltd bought a new position in Danaher in the 1st quarter valued at $6,115,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Analyst Ratings Changes

DHR has been the subject of several analyst reports. Deutsche Bank Aktiengesellschaft cut their price target on shares of Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $250.00 price objective on shares of Danaher in a report on Wednesday, April 23rd. Robert W. Baird lifted their price objective on shares of Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a report on Friday, July 18th. Wells Fargo & Company dropped their price objective on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating for the company in a report on Wednesday, July 23rd. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a report on Tuesday, April 22nd. Three investment analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $247.61.

Danaher Trading Up 0.3%

Shares of DHR stock traded up $0.62 during mid-day trading on Friday, reaching $210.84. The stock had a trading volume of 3,210,213 shares, compared to its average volume of 4,658,279. The stock's 50-day moving average price is $199.94 and its two-hundred day moving average price is $199.71. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.90. The firm has a market capitalization of $150.97 billion, a PE ratio of 44.86, a price-to-earnings-growth ratio of 2.94 and a beta of 0.73. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company had revenue of $5.94 billion for the quarter, compared to analysts' expectations of $5.83 billion. During the same quarter in the previous year, the company earned $1.72 earnings per share. Danaher's quarterly revenue was up 3.4% on a year-over-year basis. Equities analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.